Vascular smooth muscle contraction is regulated by intracellular calcium through the calmodulin-myosin light chain kinase pathway. Vasodilation occurs through decreased calcium and activation of relaxation pathways (cGMP, cAMP). Autoregulation maintains constant blood flow despite changing perfusion pressure through myogenic, metabolic, and endothelial mechanisms. Endothelial cells secrete vasodilators (NO, prostacyclin) and vasoconstrictors (endothelin) that fine-tune vascular tone.
Understand the calcium-signaling cascade from receptor to contraction. Study myogenic autoregulation (Bayliss effect) and metabolic autoregulation (adenosine, lactate accumulation). Examine how endothelial dysfunction contributes to hypertension.
Vascular smooth muscle differs from skeletal muscle in one critical respect: it lacks troponin. Instead of calcium triggering troponin to unblock myosin-binding sites on actin, smooth muscle calcium binds calmodulin, a regulatory protein. The calcium–calmodulin complex then activates myosin light chain kinase (MLCK), which phosphorylates myosin, enabling cross-bridge cycling. Relaxation happens when a phosphatase removes that phosphate group. This pathway is slower and more sustained than skeletal muscle contraction — appropriate for maintaining background vascular tone (the continuous partial contraction that keeps blood vessels at a regulated diameter) rather than producing rapid, discrete contractions.
Vascular tone is fine-tuned from multiple directions. The endothelium — the single cell layer lining every blood vessel — acts as a sensor and signaling hub. When blood flow increases (shear stress) or when acetylcholine binds endothelial receptors, endothelial cells produce nitric oxide (NO), which diffuses into underlying smooth muscle and activates guanylyl cyclase, raising cGMP. Elevated cGMP activates protein kinase G, which reduces intracellular calcium and stimulates the phosphatase that dephosphorylates myosin — the net result is vasodilation. Prostacyclin operates through a cAMP pathway to similar effect. Conversely, endothelin-1 released by endothelial cells powerfully promotes vasoconstriction by raising smooth muscle calcium. The balance between these signals determines baseline tone.
Autoregulation is the remarkable ability of blood vessels to maintain approximately constant flow to a tissue despite changes in perfusion pressure. It has three mechanisms that work together. The myogenic mechanism (Bayliss effect) is intrinsic to smooth muscle itself: stretch caused by elevated blood pressure directly depolarizes the smooth muscle cell membrane, opening voltage-gated calcium channels and causing contraction — the vessel narrows to resist the higher pressure and protect downstream capillaries. Metabolic autoregulation acts in the opposite condition: when a tissue is metabolically active (exercising muscle, firing neurons), it produces vasodilators — adenosine, carbon dioxide, lactate, K⁺, and a fall in local PO₂ — that relax smooth muscle and increase blood flow to meet demand. These signals override myogenic tone and ensure that active tissues receive more blood automatically.
Understanding this system explains a large swath of cardiovascular pathophysiology. Endothelial dysfunction — the impaired ability to produce NO — is a central mechanism in hypertension, atherosclerosis, and diabetes-related vascular disease. Drugs like nitroglycerin (which donates NO) and ACE inhibitors (which reduce angiotensin II, a potent vasoconstrictor) work precisely by manipulating the calcium-signaling and endothelial pathways you now understand. Autoregulation failure explains why severe hypertension can break through autoregulation in the brain and cause hypertensive encephalopathy, or why hypotension can cause ischemia in organs with limited autoregulatory range.